Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
3 papers
This review examines studies on how testosterone relates to anxiety and depression and how that might help explain sex differences in these disorders. About 18% of U.S. adults have an anxiety disorder each year and about 7% have major depressive disorder, and women are more than twice as likely as…
The researchers repeatedly measured early-morning cortisol and self-reported depressive symptoms in a population of adolescents. Using a statistical method to find subgroups, they identified a high-risk group (17% of the sample) with both high depressive symptoms and elevated morning cortisol. Membership in this group was linked to worse autobiographical memory…
SPRAVATO (esketamine) is a prescription nasal spray for adults with treatment‑resistant depression to be used together with an oral antidepressant. It must be given and watched by a healthcare provider because it can cause sedation, dissociation, and increases in blood pressure. Patients are observed for at least two hours after…
